![John H. Morrison](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John H. Morrison
Director/Board Member at Neurome, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Warren G. Young | M | - |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | 24 years |
Kristján Tómas Ragnarsson | M | 80 |
Icahn School of Medicine at Mount Sinai
| - |
Tom Strauss | M | 82 |
Icahn School of Medicine at Mount Sinai
| - |
Kevin David Costa | M | - |
Icahn School of Medicine at Mount Sinai
| 15 years |
Michael R. Hausman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Eric Schadt | M | 59 |
Icahn School of Medicine at Mount Sinai
| 13 years |
Alain Carpentier | M | 91 |
Icahn School of Medicine at Mount Sinai
| - |
John R. Tomasula | M | 69 |
Icahn School of Medicine at Mount Sinai
| 22 years |
Ross L. Cagan | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Barbara Paris | M | 72 |
Icahn School of Medicine at Mount Sinai
| 21 years |
Hina Waheed Chaudhry | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Scott L. Friedman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Robert J. Desnick | M | - |
Icahn School of Medicine at Mount Sinai
| 15 years |
Gary Goldenberg | M | 47 |
Icahn School of Medicine at Mount Sinai
| 15 years |
Jeffrey Vacirca | M | 55 |
Icahn School of Medicine at Mount Sinai
| 6 years |
Andrew Russell | M | 52 |
Icahn School of Medicine at Mount Sinai
| 9 years |
Sundar Jagannath | M | - |
Icahn School of Medicine at Mount Sinai
| - |
George M. Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Stephen Dahmer | M | 49 |
Icahn School of Medicine at Mount Sinai
| 9 years |
Peter Sordillo | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Joshua Brody | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Edward Lung | M | - |
Icahn School of Medicine at Mount Sinai
| 21 years |
Lisa Edelmann | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Lawrence Tanenbaum | M | 66 |
Icahn School of Medicine at Mount Sinai
| 16 years |
Judy Cho | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Elissa Levin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Dennis Charney | M | 72 |
Icahn School of Medicine at Mount Sinai
| 20 years |
Jay Schechtman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Preeti Parikh | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Stephen B. Thacker | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Michael Khoury | M | 70 |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | - |
Steven J. Burakoff | M | 81 |
Icahn School of Medicine at Mount Sinai
| - |
Melvin M. van Woert | M | 93 |
Icahn School of Medicine at Mount Sinai
| 46 years |
Robert J. Sutcliffe | M | 72 |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | - |
Samuel Marcus Waxman | M | - |
Icahn School of Medicine at Mount Sinai
| 41 years |
Lester B. Salans | M | 88 |
Icahn School of Medicine at Mount Sinai
| - |
Ariel Recanati | M | 60 |
Icahn School of Medicine at Mount Sinai
| - |
Joseph Wender | M | 79 |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | - |
Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 years |
Michael Donovan | M | 70 |
Icahn School of Medicine at Mount Sinai
| 13 years |
Holly G. Atkinson | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Andrew M. Saul | M | 77 |
Icahn School of Medicine at Mount Sinai
| - |
Francesco Ramirez | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Najla L. Aftahi | F | - |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | 21 years |
Christina M. Madrid | F | - |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | - |
Carlos Cordón-Cardó | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Steve Hochberg | M | 62 |
Icahn School of Medicine at Mount Sinai
| - |
Janice L. Gabrilove | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Arthur A. Klein | M | 76 |
Icahn School of Medicine at Mount Sinai
| - |
E. Premkumar Reddy | M | 80 |
Icahn School of Medicine at Mount Sinai
| 14 years |
Hendrick Coenraad Hemker | M | 90 |
Icahn School of Medicine at Mount Sinai
| - |
Angela Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Lisa Satlin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Floyd E. Bloom | M | 87 |
Neurome, Inc.
![]() Neurome, Inc. Miscellaneous Commercial ServicesCommercial Services Neurome, Inc. provides therapeutic solutions to human neurodegenerative diseases. It develops proprietary technologies to reveal and quantify gene expression patterns and the resultant morphological details of brain structures in normal and pathological brains. The company was co-founded by Floyd E. Bloom, Warren G. Young and John H. Morrison in October, 2000 and is headquartered in La Jolla, CA. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 54 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John H. Morrison
- Personal Network